Answer
No pharmaceutical incompatibilities are specified for Inbrija 33 mg levodopa inhalation capsules; the incompatibilities section states “Not applicable.”
Sources for this answer
- Inbrija 33mg inhalation powder, hard capsuleMerz Pharma UK Ltd · emc · SmPC §6.2 Incompatibilities · Version 2Document updated
Sources checked